Mar 28, 2016
OliX Pharmaceuticals, Inc., the leading RNAi therapeutics biotech in Asia, has designated Guangzhou RiboBio, Inc. a preferred manufacturer of its oligonucleotides.
Jan 08, 2016
OliX Pharmaceuticals, Inc. (OliX) today announced that Dmitry Samarsky, PhD, has joined the company as Senior Vice President of Technology and Global Business Development. Dr.